This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The University of North Carolina at Chapel Hill, Southern Research Institute. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019-2021
Title: Innovations of Inventor Xin Ming
Introduction
Xin Ming is a notable inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of nucleic acid delivery, holding 2 patents that focus on enhancing the activity of oligonucleotides. Her work is particularly relevant for medical applications, including treatments for disorders such as cystic fibrosis.
Latest Patents
One of her latest patents is titled "Benzimidazoles that enhance the activity of oligonucleotides." This disclosure outlines methods, compounds, and compositions for delivering nucleic acids to specific cells. It emphasizes the effectiveness of certain salts in delivering nucleic acids to lung cells, which is crucial for treating conditions like cystic fibrosis. Another significant patent is "Small molecules that enhance the activity of oligonucleotides." This patent describes methods for administering oligonucleotides into cells, both in vitro and in vivo, using small organic compounds to improve delivery and activity.
Career Highlights
Xin Ming has worked with prestigious institutions, including the University of North Carolina at Chapel Hill and Southern Research Institute. Her research has contributed to advancements in the field of molecular biology and therapeutic development.
Collaborations
Some of her notable coworkers include Rudolph L. Juliano and William Perry Janzen. Their collaborative efforts have furthered the understanding and application of oligonucleotide technologies.
Conclusion
Xin Ming's innovative work in enhancing oligonucleotide activity has the potential to significantly impact medical treatments, particularly for genetic disorders. Her contributions to the field are invaluable and continue to inspire future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile